Lanthanide Metal–Organic Frameworks Enable Target-Triggered CRISPR-Cas12a Activator Release for Ultrasensitive Non-nucleic Acid Biomarker Detection
Analytical Chemistry · 2026
DOI: 10.1021/acs.analchem.6c01959 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2026. Verfasst von Yongzhen Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid and Breast Surgery, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan430071, Ch…. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Lanthanoid Series Elements, Metal-Organic Frameworks, Biosensing Techniques. Die Arbeit nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Hubei Provincial Postdoctoral Pioneer Talent Tracking Program, Wuhan Top-Notch Talent Program.
Abstract (Originalsprache)
Rapid, ultrasensitive detection of cardiac troponin I (cTnI) is critical for the early diagnosis of acute myocardial infarction (AMI). However, CRISPR-Cas systems, despite their unparalleled nucleic acid detection performance, face inherent bottlenecks in protein sensing, including inefficient signal transduction, high background noise, and insufficient anti-interference capability in complex biological matrices. Herein, we report a modular fluorescence signal transduction platform integrating aptamer-functionalized magnetic beads, lanthanide metal–organic frameworks (Ln-MOFs) with high nucleic acid affinity, and CRISPR-Cas12a–mediated collateral cleavage amplification for sensitive cTnI detection. Target cTnI binding to magnetic bead-immobilized aptamers drives the formation of sandwich complexes with CRISPR activator DNA (act)–functionalized Ln-MOFs, triggering phosphate-mediated release of act. The liberated act initiates robust Cas12a trans-cleavage activity, generating an amplified fluorescence readout. This platform achieves a limit of detection (LOD) of 0.1 pg mL–1 in serum samples, with excellent specificity against off-target interfering proteins. Validation in 28 clinical serum samples demonstrates near-perfect agreement with standard clinical ELISA measurements and yields an area under the curve (AUC) of 0.995, confirming its clinical diagnostic accuracy. Furthermore, the modular design enables facile reconfiguration for diverse protein biomarkers via aptamer substitution, providing a universal strategy to expand CRISPR-Cas systems toward non-nucleic acid target detection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Thyroid and Breast Surgery, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan430071, China.
- Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Ministry of Education), School of Pharmaceutical Sciences, Wuhan University, Wuhan430071, China.
- Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Hubei Provincial Clinical Research Center for Molecular Diagnostics, Wuhan430071, China.
- Department of Cardiology, Zhongnan Hospital of Wuhan University, Institute of Myocardial Injury and Repair, Wuhan University, Wuhan430071, China.
ORCID-Profile: Long Yu, Yuxiu Xiao
Förderung
- National Natural Science Foundation of China
- Hubei Provincial Postdoctoral Pioneer Talent Tracking Program
- Wuhan Top-Notch Talent Program
- Hubei Provincial Clinical Research Center for Molecular Diagnostics
Zitieren
APA
Liu, Y., Yu, L., Shen, Y., Gan, Z., Tong, J., Zhao, F., & Xiao, Y. (2026). Lanthanide Metal–Organic Frameworks Enable Target-Triggered CRISPR-Cas12a Activator Release for Ultrasensitive Non-nucleic Acid Biomarker Detection. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.6c01959
Vancouver
Liu Y, Yu L, Shen Y, Gan Z, Tong J, Zhao F, et al. Lanthanide Metal–Organic Frameworks Enable Target-Triggered CRISPR-Cas12a Activator Release for Ultrasensitive Non-nucleic Acid Biomarker Detection. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.6c01959
BibTeX
@article{Liu2026,
author = {Liu, Yongzhen and Yu, Long and Shen, Yongjin and Gan, Zhiwen and Tong, Jiyu and Zhao, Fang and Xiao, Yuxiu},
title = {Lanthanide Metal–Organic Frameworks Enable Target-Triggered CRISPR-Cas12a Activator Release for Ultrasensitive Non-nucleic Acid Biomarker Detection},
journal = {Analytical Chemistry},
year = {2026},
doi = {10.1021/acs.analchem.6c01959}
}
EUVIMED